Mereo BioPharma Group PLC (NAS:MREO)
$ 4.05 -0.04 (-0.98%) Market Cap: 623.10 Mil Enterprise Value: 547.99 Mil PE Ratio: 0 PB Ratio: 7.94 GF Score: 36/100

Mereo Biopharma Group PLC at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 12:55 AM GMT
Release Date Price: $0.758 (-4.29%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MREO.OQ - Mereo BioPharma Group plc
Mereo Biopharma Group PLC at Jefferies London Healthcare Conference
Nov 16, 2022 / 12:55AM GMT

=====================
Corporate Participants
=====================
* Denise Scots-Knight
Mereo BioPharma Group PLC - CEO
* Jackie Parkin
Mereo BioPharma Group PLC - SVP & Therapeutic Head

=====================
Conference Call Participants
=====================
* Maury Raycroft
Jefferies - Analyst

=====================
Questions and Answers
--------------------------------------------------------------------------------
Maury Raycroft, Jefferies - Analyst [1]
--------------------------------------------------------------------------------
My name is Maury Raycroft and I am one of the biotech analysts at Jefferies. Thanks for joining us today in London. I'd like to welcome the Mereo team: Denise Knight Scot -- Scots-Knight, sorry -- and also joined by Jackie Parkin from -- SVP. So thanks so much for joining us today. Maybe to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot